as well as antibodies isolated from humans who had recovered from COVID-19. Scientists from Regeneron selected the two most potent, non-competing virus-neutralising antibodies and scaled up ...

Researchers have shown a new drug compound can prevent long COVID symptoms in mice—a landmark finding that could lead to a ...

NIH cuts target $1.6 billion RECOVER initiative to study and improve treatment of long COVID, putting further research gains ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, ...

Legalcategory· October 4, 2024 Regeneron loses key defense in COVID-19 treatment patent lawsuit Biotech company Regeneron Pharmaceuticals lost a bid on Friday to be held immune from allegations ...

The body then produces antibodies that can fight the coronavirus. Regeneron’s name might indicate that it’s a pharmaceutical company. However, Regeneron actually meets the definition of a ...

Researchers have shown a new drug compound can prevent long COVID symptoms in mice – a landmark finding that could lead to a future treatment for the debilitating condition. The world-first study ...